The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer

Table 1

Clinicopathological correlations of SLDH in gastric cancer.

Variable	Normal SLDH (342)   (%)	High SLDH (23)   (%)
Age (y)			0.675
<60	208 (93.3)	15 (6.7)
≥60	134 (94.4)	8 (5.6)
Gender			0.610
Male	226 (94.2)	14 (5.8)
Female	116 (92.8)	9 (7.2)
Tumor size (cm)			0.252
≤4	181 (92.3)	15 (7.7)
>4	161 (95.3)	8 (4.7)
Borrmann type			0.092
I	9 (81.8)	2 (18.2)
II	68 (97.1)	2 (2.9)
III	226 (94.2)	14 (5.8)
IV	39 (88.6)	5 (11.4)
Histological type			0.521
Well diff. ade.	6 (85.7)	1 (14.3)
Moderately diff. ade.	80 (96.4)	3 (3.6)
Poorly diff. ade.	249 (92.9)	19 (7.1)
Undifferentiated ade.	4 (100)	0 (0)
Squamous cell ca.	3 (100)	0 (0)
pT stage			0.011^*
T1	31 (96.9)	1 (3.1)
T2	29 (100)	0 (0)
T3	222 (95.3)	11 (4.7)
T4	60 (84.5)	11 (15.5)
pN stage			0.106
N0	82 (97.6)	2 (2.4)
N1	148 (94.3)	9 (5.7)
N2	72 (92.3)	6 (7.7)
N3	40 (97.0)	6 (1.3)
Metastasis			0.012^*
No	279 (95.5)	13 (4.5)
Yes	63 (86.3)	10 (13.7)
pTNM stage			0.001^*
I	41 (97.6)	1 (2.4)
II	54 (94.7)	3 (5.3)
III	155 (97.5)	4 (2.5)
IV	92 (86.0)	15 (14.0)
Recurrence			0.012^*
No	210 (96.3)	8 (3.7)
Yes	132 (89.8)	15 (10.2)

SLDH: serum lactate dehydrogenase; ade.: adenocarcinoma; diff.: differentiated; ca.: carcinoma; .